Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles

PurposeTo examine the immunogenicity of diphtheria toxoid (DT) loaded mesoporous silica nanoparticles (MSNs) after coated and hollow microneedle-mediated intradermal immunization in mice.MethodsDT was loaded into MSNs and the nanoparticle surface was coated with a lipid bilayer (LB-MSN-DT). To prepare coated microneedles, alternating layers of negatively charged LB-MSN-DT and positively charged N-trimethyl chitosan (TMC) were coated onto pH-sensitive microneedle arrays via a layer-by-layer approach. Microneedle arrays coated with 5 or 3 layers of LB-MSN-DT were used to immunize mice and the elicited antibody responses were compared with those induced by hollow microneedle-injected liquid formulation of LB-MSN-DT. Liquid DT formulation with and without TMC (DT/TMC) injected by a hollow microneedle were used as controls.ResultsLB-MSN-DT had an average size of about 670 nm and a zeta potential of −35 mV. The encapsulation efficiency of DT in the nanoparticles was 77%. The amount of nano-encapsulated DT coated onto the microneedle array increased linearly with increasing number of the coating layers. Nano-encapsulated DT induced stronger immune responses than DT solution when delivered intradermally via hollow microneedles, but not when delivered via coated microneedles.ConclusionBoth the nano-encapsulation of DT and the type of microneedles affect the immunogenicity of the antigen.

[1]  V. Mourya,et al.  Trimethyl chitosan and its applications in drug delivery , 2009, Journal of materials science. Materials in medicine.

[2]  W. Jiskoot,et al.  Impact-Insertion Applicator Improves Reliability of Skin Penetration by Solid Microneedle Arrays , 2014, The AAPS Journal.

[3]  J. Moon,et al.  Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy , 2015, Vaccines.

[4]  W. Jiskoot,et al.  Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations , 2010, Pharmaceutical Research.

[5]  D. Irvine,et al.  Particulate vaccines: on the quest for optimal delivery and immune response. , 2011, Drug discovery today.

[6]  N. Mitter,et al.  Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein. , 2014, Biomaterials.

[7]  Koen van der Maaden,et al.  Layer-by-Layer Assembly of Inactivated Poliovirus and N-Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[8]  N. Mitter,et al.  Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery. , 2013, Nanoscale.

[9]  I. Toth,et al.  Modern Subunit Vaccines: Development, Components, and Research Opportunities , 2013, ChemMedChem.

[10]  Koen van der Maaden,et al.  Hollow microneedle‐mediated micro‐injections of a liposomal HPV E743–63 synthetic long peptide vaccine for efficient induction of cytotoxic and T‐helper responses , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[11]  N. Mitter,et al.  Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. , 2013, Small.

[12]  W. Jiskoot,et al.  Immune Modulation by Adjuvants Combined with Diphtheria Toxoid Administered Topically in BALB/c Mice After Microneedle Array Pretreatment , 2009, Pharmaceutical Research.

[13]  W. Saltzman,et al.  Controlled release for local delivery of drugs: barriers and models. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[14]  A. Boyle,et al.  Mesoporous Silica Nanoparticles with Large Pores for the Encapsulation and Release of Proteins. , 2016, ACS applied materials & interfaces.

[15]  S. Nakagawa,et al.  Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers. , 2011, Vaccine.

[16]  W. Jiskoot,et al.  Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  J. Bouwstra,et al.  Dissolving Microneedle Patches for Dermal Vaccination , 2017, Pharmaceutical Research.

[18]  B. Greenwood The contribution of vaccination to global health: past, present and future , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[19]  C. Oomens,et al.  Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[20]  T. Grimmond,et al.  Exposure Survey of Trends in Occupational Practice (EXPO‐S.T.O.P.) 2015: A national survey of sharps injuries and mucocutaneous blood exposures among health care workers in US hospitals , 2017, American journal of infection control.

[21]  Koen van der Maaden,et al.  Microneedle technologies for (trans)dermal drug and vaccine delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[23]  D. Irvine,et al.  Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. , 2012, ACS nano.

[24]  Thomas Hankemeier,et al.  Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats , 2014, Pharmaceutical Research.

[25]  W. Hennink,et al.  Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. , 2007, Vaccine.

[26]  I. Toth,et al.  Modern Subunit Vaccines: Development, Components, and Research Opportunities , 2013 .

[27]  Chun-Xia Zhao,et al.  Nanoparticle vaccines. , 2014, Vaccine.

[28]  Abraham J. Koster,et al.  Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[29]  J. Leask,et al.  Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. , 2017, Vaccine.

[30]  Nanolayered chemical modification of silicon surfaces with ionizable surface groups for pH-triggered protein adsorption and release: application to microneedles. , 2013, Journal of materials chemistry. B.

[31]  C. Russell Middaugh,et al.  Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.

[32]  R. Bronaugh,et al.  Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. , 1982, Toxicology and applied pharmacology.

[33]  W. Jiskoot,et al.  Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[34]  W. Jiskoot,et al.  Adjuvant effect of cationic liposomes and CpG depends on administration route. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Elly van Riet,et al.  Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Ryan F. Donnelly,et al.  Microneedles: A New Frontier in Nanomedicine Delivery , 2016, Pharmaceutical Research.

[37]  M. Prausnitz,et al.  Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays , 2009, PLoS ONE.

[38]  S. Reed,et al.  Key roles of adjuvants in modern vaccines , 2013, Nature Medicine.

[39]  Koen van der Maaden,et al.  Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery , 2017, Pharmaceutical Research.